Aeglea BioTherapeutics
diverse in antibody discovery and engineering enables potentially best in class therapeutics | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
53 of 56
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
September 2023
diverse in antibody discovery and engineering enables potentially best in class therapeutics as | Aeglea BioTherapeutics
Related slides by other companies
Absci
Investor Presentation
December 2023
reverse immunology simultaneous target and antibody discovery gees | Absci
AbCellera
Investor Conference
April 2023
be best in world in antibody therapeutics from target to the clinic build a large and diversified portfolio of stakes in future antibody therapeutics dao | AbCellera
Absci
Investor Presentation
October 2023
the leading full stack platform for drug creation sos | Absci
AbCellera
Investor Presentation
May 2023
be best in world in antibody therapeutics from target to the clinic build a large and diversified portfolio of stakes in future antibody therapeutics | AbCellera
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io